Targeting selenoprotein H in the nucleolus suppresses tumors and metastases by ...



- Apr 17
Efficacy of Carrimycin in the Treatment of Two Patients with Severe Coronavirus Disease 2019

- Nov 16, 2021
Seven Achievements of the Chinese Academy of Medical Sciences Appear in the National "13th Five ...

- Jan 5, 2021
COVID-19 treatment is the first synthetic biological drug to receive FDA approval for Phase 3 trials

- Jan 4, 2021
FDA approves Phase III trial of synthetic biological COVID-19 treatment

- Dec 28, 2020
First Synthetic Biological Drug for COVID-19 to Receive FDA Approval for Phase III Trials

- Dec 24, 2020
FDA AUTHORIZES PH3 CLINICAL TRIALS FOR COVID-19 THERAPEUTIC CARRIMYCIN

- Apr 16, 2020
“Shenyang Smart Manufacturing” Incorporated Into Global Anti-epidemic “China’s plan”

- Apr 15, 2020
New Progress Made in China’s Treatment of COVID-19

- Mar 27, 2020
Ministry of Science and Technology of the PRC: Carrimycin IS Effective In The Treatment of COVID-19

- Mar 26, 2020
Chinese Primary Drug Carrimycin is Effective in the Treatment of COVID-19

- Jan 16, 2020
Carrimycin, Chinese Academy of Medical Sciences Won National Awards and Received Global Attention

- Jan 4, 2020
Carrimycin Firstly Appeared in the Official List of Effective Drugs Against COVID-19